Company Filing History:
Years Active: 2004-2014
Title: Ramakrishna Sistla: Innovator in Pharmaceutical Chemistry
Introduction
Ramakrishna Sistla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, his work focuses on innovative processes for synthesizing important chemical compounds.
Latest Patents
One of his latest patents is the "Process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate." Hexadecyl cis-9-tetradecenoate, commonly known as Cetyl myristoleate (CMO), is utilized in the treatment of osteoarthritis and other joint inflammatory diseases. The synthesis of cis-9-tetradecenoic acid methyl ester from oleic acid methyl ester is a key aspect of this invention. Given the limited natural sources for cis-9-tetradecenoic acid, this innovative approach aims to provide a reliable method for its production. Additionally, he has developed a process for synthesizing "1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines," which are useful as hypoglycemic agents in diabetes treatment.
Career Highlights
Ramakrishna Sistla is affiliated with the Council of Scientific and Industrial Research, where he has been instrumental in advancing research in pharmaceutical chemistry. His work has not only contributed to scientific knowledge but also has practical implications for health and medicine.
Collaborations
He has collaborated with notable colleagues, including Lakshmi Anu Prabhavathi Devi Bethala and Nadpi Gangadhar Katkam, enhancing the scope and impact of his research.
Conclusion
Ramakrishna Sistla's innovative work in pharmaceutical chemistry exemplifies the importance of research and development in creating effective treatments for various health conditions. His contributions continue to influence the field and improve patient outcomes.